Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Feb. 4, 2014

View Archived Issues

Washington roundup: VAD readmissions hold steady despite rising COPD, atrial fib

FDA clears PillCam COLON for following incomplete colonoscopy

Grants roundup: Tasso simplifies blood sampling, secures $2.3 million in funding

Financings roundup: MELA Sciences reports details of its recent private placement

Agreements/contracts: Definiens extends testing collaboration with Clarient

HIT roundup: Telemedicine app helps prevent unnecessary CT scans in kids

Products

People in Places

MDD's Cardiology Extra

Deals roundup: Smith & Nephew in bid to acquire ArthroCare for $1.7 billion in cash

Smith & Nephew (S&N; London) reported the execution of a definitive agreement to acquire ArthroCare (Austin) for about $1.7 billion. Read More

Report from Europe: GI's EndoBarrier received into German reimbursement system

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...